First line treatment of adult men with mCRPC who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated.
Rapid Review
Commenced | Completed | Outcome |
5/11/2014 | 22/12/2014 | Full Pharmacoeconomic Evaluation Recommended. |
Pharmacoeconomic Evaluation
Commenced | Completed | Outcome |
09/04/2015 | 22/06/2015 | Reimbursement Not Recommended at the submitted price. |
December 2015
The HSE has approved reimbursement following confidential price negotiations.